Here is a detailed physiological account of the immune response, drawn from Cellular and Molecular Immunology (Abbas et al.) and Robbins & Kumar Basic Pathology.
Immune Response — Physiology
The immune response operates as a highly coordinated physiological system involving cellular recognition, intracellular signaling, clonal expansion, effector function, and regulated resolution.
1. Physiological Sequence of Events
When a pathogen breaches host barriers, the immune response unfolds in overlapping phases:
Pathogen entry
│
▼
Innate recognition (minutes–hours)
│
▼
Antigen capture & presentation by DCs (hours–day 1)
│
▼
Adaptive activation: T cell & B cell responses (days 3–5)
│
▼
Effector phase: antibodies, cytotoxic killing, macrophage activation
│
▼
Memory formation + response contraction
2. Innate Immune Physiology
Pattern Recognition & Signal Transduction
Innate immune cells (macrophages, DCs, neutrophils, epithelial cells) detect pathogens via pattern recognition receptors (PRRs):
| Receptor Class | Location | Triggers | Downstream Effect |
|---|
| TLRs (Toll-like receptors) | Plasma membrane / endosomes | Bacterial LPS, viral RNA/DNA | NF-κB activation → pro-inflammatory cytokines (TNF-α, IL-1, IL-6, IL-12), Type I IFNs |
| NLRs (NOD-like receptors) | Cytosol | Uric acid, ATP, microbial fragments | Inflammasome → Caspase-1 activation → IL-1β, IL-18 production |
| RIG-I-like receptors | Cytosol | Viral dsRNA | IRF3/IRF7 activation → Type I interferons (IFN-α/β) |
| C-type lectins | Plasma membrane | Fungal/bacterial polysaccharides | Phagocytosis, inflammatory signaling |
Inflammasome physiology: NLRs (e.g., NLRP3) sense cell stress → assemble a cytosolic platform → activate caspase-1 → cleave pro-IL-1β into IL-1β → fever, leukocyte recruitment, systemic acute-phase response. This pathway underlies gout (urate crystals), autoinflammatory syndromes, and contributes to atherosclerosis and metabolic syndrome.
Innate Effector Mechanisms
1. Inflammation:
- Cytokines (TNF-α, IL-1β, IL-6) and complement fragments (C3a, C5a) act on vascular endothelium
- Vasodilation + increased permeability → edema, heat, redness
- Leukocyte recruitment: selectins (rolling) → integrins (adhesion) → chemokines (migration to tissue)
- Recruited neutrophils and macrophages phagocytose and destroy pathogens
2. Antiviral defense:
- Virus-infected cells produce Type I IFNs (IFN-α, IFN-β)
- IFNs act on neighboring cells → upregulate antiviral enzymes (RNase L, PKR) → degrade viral RNA, halt translation
- NK cells recognize loss of MHC I on infected/tumor cells → release perforin + granzymes → target cell apoptosis
3. Complement System Physiology
The complement system amplifies innate defense via a cascade of >20 serum proteins. The critical step is cleavage of C3 by C3 convertase, generating C3a and C3b.
Fig. 2.8 — Robbins & Kumar: Three complement activation pathways all converge on C3 convertase.
Three Activation Pathways
| Pathway | Trigger | Initiating Step |
|---|
| Classical | Antigen–antibody complexes (IgM or IgG bound to antigen) | C1q binds Fc region → C1r/s activated → cleaves C4 + C2 → C3 convertase (C4b2a) |
| Alternative | Microbial surfaces (LPS, polysaccharides) — no antibody needed | Spontaneous C3 hydrolysis → C3b deposits on surface → Factor B + D form C3 convertase (C3bBb), stabilized by properdin |
| Lectin | Mannose-binding lectin (MBL) binds microbial mannose | MBL–MASP complex activates C4 + C2 → same C3 convertase as classical pathway |
Effector Functions of Complement
| Product | Function |
|---|
| C3b, iC3b | Opsonization — coat microbes for phagocytosis via CR1/CR3 on phagocytes |
| C3a, C4a, C5a ("anaphylatoxins") | Mast cell degranulation (histamine), vasodilation, neutrophil recruitment |
| C5b-9 (MAC) | Membrane Attack Complex — polymerized C9 pores → osmotic lysis of thin-walled bacteria (especially Neisseria) |
Regulation of Complement
Normal host cells express inhibitory proteins to prevent self-damage:
- DAF (CD55) — displaces Bb from C3 convertase; prevents convertase assembly
- CD59 — blocks MAC formation on host cells
- Factor H — promotes iC3b formation (inactivates C3b); prefers sialic acid–rich host surfaces
- C1 INH — blocks classical pathway initiation; deficiency → hereditary angioedema
- Loss of GPI-anchored proteins (DAF + CD59) → paroxysmal nocturnal hemoglobinuria (PNH): uncontrolled complement lysis of RBCs
4. T Cell Activation Physiology
T cell activation requires three distinct signals:
| Signal | Mediator | Role |
|---|
| Signal 1 | TCR–MHC/peptide interaction | Antigen specificity; triggers TCR signaling cascade (ZAP-70, PLC-γ → IP3/DAG → Ca²⁺ → NFAT; PKC → NF-κB; RAS → MAPK/AP-1) |
| Signal 2 | CD28 (on T cell) + B7/CD80/CD86 (on APC) | Costimulation; activates PI3K → AKT (cell survival, metabolism), amplifies NF-κB, promotes IL-2 production |
| Signal 3 | Cytokines (IL-12, IL-4, IL-6, TGF-β) | Directs T-helper subset differentiation |
Without Signal 2: TCR engagement alone induces anergy (functional unresponsiveness) or apoptosis — a key mechanism of self-tolerance.
Physiological Sequence of T Cell Activation
Cellular and Molecular Immunology: Naive T cells are activated in lymphoid organs; effector cells migrate to peripheral tissues.
- Naïve T cells circulate through secondary lymphoid organs (lymph nodes, spleen), guided by CCR7 along fibroblastic reticular cell (FRC) conduits
- Mature DCs — loaded with antigen from peripheral tissues — migrate to T cell zones and display peptide–MHC complexes + B7 costimulators
- TCR scanning: T cells make transient contacts with DCs; antigen recognition causes T cell arrest → stable immunological synapse forms
- Signal cascade: TCR + CD28 → IL-2 secretion + upregulation of IL-2 receptor (CD25) → autocrine proliferation (clonal expansion)
- Differentiation into effector subsets (driven by cytokine milieu) and memory cells
- Effector T cells migrate to peripheral tissues; re-encounter antigen on local APCs/infected cells → execute effector functions
T Helper Subset Polarization (Signal 3)
| Cytokine environment | Subset | Key effector cytokines | Protection against |
|---|
| IL-12, IFN-γ | Th1 | IFN-γ, TNF-α | Intracellular pathogens (bacteria, viruses) |
| IL-4 | Th2 | IL-4, IL-5, IL-13 | Parasites; drives IgE, eosinophils |
| IL-6 + TGF-β (+ IL-23 for maintenance) | Th17 | IL-17A/F, IL-22 | Extracellular bacteria, fungi; neutrophil recruitment |
| TGF-β + IL-2 | Treg | IL-10, TGF-β | Suppression; self-tolerance |
CD8⁺ CTL Killing Mechanism
CTLs recognize peptide on MHC I (on all nucleated cells):
- Perforin: polymerizes in target cell membrane → forms pores
- Granzymes: serine proteases enter via pores → activate caspases → apoptosis
- Fas–FasL interaction: CTL expresses FasL → binds Fas on target → apoptosis
- CTLs are themselves protected from their own perforin by a lysosomal glycoprotein (LAMP-1)
5. B Cell Activation & Antibody Physiology
B cells are activated by T-cell help (for protein antigens — T-dependent) or by direct crosslinking (T-independent, e.g., polysaccharides):
T-dependent B cell activation (germinal center reaction):
- B cell receptor (BCR) binds antigen → internalizes and presents peptide on MHC II to helper T cell
- CD40L (on T cell) engages CD40 (on B cell) → key costimulatory signal
- Th2-derived IL-4/IL-13, Th1-derived IFN-γ, etc. → class switch recombination (CSR):
- IgM (primary, no T help needed) → IgG (opsonization, complement) → IgA (mucosal) → IgE (parasite/allergy)
- Somatic hypermutation in germinal centers → affinity maturation → selection of high-affinity B cell clones
- Differentiation into plasma cells (antibody factories) and memory B cells
Antibody Effector Mechanisms
| Mechanism | How it works |
|---|
| Neutralization | Antibodies block pathogen–receptor interactions; prevent cell entry |
| Opsonization | IgG Fc recognized by FcγRs on macrophages/neutrophils → enhanced phagocytosis |
| Complement activation | IgM/IgG–antigen complexes activate classical pathway → C3b deposition → MAC |
| ADCC | IgG-coated targets recognized by NK cell FcγRIII (CD16) → target cell killing |
| Mast cell degranulation | IgE crosslinked on mast cells → histamine, leukotrienes release (allergy/parasites) |
6. Physiological Resolution & Memory
- After pathogen clearance, 90–95% of effector cells undergo apoptosis (contraction) — mediated partly by withdrawal of survival signals (IL-2, costimulation)
- Surviving ~5% become long-lived memory cells (both T and B): lower activation threshold, faster kinetics, greater magnitude upon re-exposure
- Secondary immune response is faster (days not weeks), produces higher-affinity antibodies, and has qualitatively different effector mechanisms
Summary Flow
Pathogen → PRR signaling (TLRs/NLRs) → Cytokine release (IL-1β, TNF-α, IL-12)
↓
Inflammation + DC maturation
↓
DC → lymph node → peptide–MHC presentation
↓
Signal 1 (TCR) + Signal 2 (CD28) + Signal 3 (cytokines)
↓
IL-2 → Clonal expansion → Th1/Th2/Th17/Treg / CTL
↓
B cell help (CD40L, cytokines) → Germinal center → Antibodies
↓
Pathogen eliminated → Contraction → Memory
Sources: Cellular and Molecular Immunology — Abbas, Lichtman & Pillai (9780323757485); Robbins & Kumar Basic Pathology (9780323790185); Janeway's Immunobiology 10e (9780393884876)